Nitric Oxide Synthase Inhibitors in Refractory Cardiogenic Shock due to Myocardial Infarction after Percutaneous Coronary Intervention

Publisher： Karger

E-ISSN： 1424-0556|5|3|161-167

ISSN： 1422-9528

Source： Heart Drug, Vol.5, Iss.3, 2005-06, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention

By Hamdalla Hussam   Moliterno David J  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1669-1673

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1143-1146

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1207-1210

Informa Healthcare

Access to resources Recommend Favorite

Primary percutaneous coronary intervention for acute ST elevation myocardial infarction – first year's experience of a tertiary referral centre in the UK

By Dorsch MF   Blackman DJ   Greenwood JP   Blaxill JM   Priestley C   Hunter S   Jani M   McLenachan JM  

Clinical Medicine, Vol. 8, Iss. 3, 2008-06 ,pp. : 259-263

Royal College Of Physicians

Access to resources Recommend Favorite

Imatinib/sorafenib: Fatal myocardial infarction with cardiogenic shock: case report

By  

Reactions Weekly, Vol. 1, Iss. 1353, 2011-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite